Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Catabolite activator protein–DNA complex (CAP–DNA complex) is a fundamental regulatory assembly in prokaryotic gene expression, primarily characterized in Escherichia coli (UniProt: P0ACJ8) [1]. The complex forms when the Catabolite Activator Protein (CAP), also known as the cAMP Receptor Protein (CRP), binds to its allosteric effector, cyclic AMP (cAMP), which induces a conformational change allowing the protein to bind specifically to DNA sequences [2]. This binding results in a significant bending of the DNA, often exceeding 90 degrees, which is a critical step for the recruitment and activation of RNA polymerase at various promoters (PDB: 1CGP) [3]. The CAP–DNA complex is the central mediator of carbon catabolite repression, a mechanism that enables bacteria to prioritize the utilization of glucose over other carbon sources [4]. Beyond its metabolic role, CAP-like proteins regulate the expression of virulence factors in several human pathogens, including Vibrio cholerae and Mycobacterium tuberculosis, making the complex a potential target for the development of novel antimicrobial therapies [5]. Research into this complex has provided foundational insights into the principles of allosteric regulation and protein-DNA recognition in molecular biology [2, 3]. Citations: [1] UniProt P0ACJ8; [2] Busby & Ebright (1999) J Mol Biol; [3] Schultz et al. (1991) Science; [4] Gorke & Stulke (2008) Nat Rev Microbiol; [5] Rickman et al. (2005) Mol Microbiol.
Competitive inhibition of cAMP binding or allosteric modulation of DNA binding affinity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Catabolite activator protein–DNA complex (CAP–DNA).